Breaking
Friday, June 19, 2026

Regulatory Updates

🇺🇸 FDA Page 24

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 277–288 of 373 articles

Medium impact NewsMay 23, 2026

RFK Jr.’s Muddled Claims on Drug Approval Speed in Oncology

oncology · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 23, 2026

Five Key Regulatory Updates to Watch at ASCO

FDA · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

FDA Fast Track Designation for Oncology Drugs: April 2026 Insights

FDA · oncology · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

FDA in Flux: May 2026 Drug Approvals Update

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

Best Cancer Stocks for 2026: Investment Insights

oncology · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 22, 2026

First RAS Inhibitor Extends Survival in Metastatic Pancreatic Cancer

FDA · metastatic pancreatic adenocarcinoma · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

FDA's Guidance on Animal Testing Alternatives: Industry Concerns

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 22, 2026

Aptar Pharma Advances FDA-Funded Research Contract for Drug Approvals

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

BioMarin Seeks Approval for Voxzogo in Short Stature Indication

short stature · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 21, 2026

Atara Bounces Back with FDA Approval in Oncology

FDA · oncology · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 21, 2026

BioMarin's SWOT Analysis: Competitive Headwinds in Rare Disease Biotech

rare disease · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 21, 2026

New FDA Guidance on ENDS and Nicotine Pouch Products

FDA · 2 min

Dr. Sarah Mitchell